A. Charbonnier

P. Chevallier, D. Blaise, M. Mohty, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[Haploidentical hematopoietic stem cell transplantation: Guidelines from the Francophone society of marrow transplantation and cellular therapy (SFGM-TC)].

I. Yakoub-Agha, D. Blaise, F. Suarez, 2016, Bulletin du cancer.

Late relapse after hematopoietic stem cell transplantation for acute leukemia: a retrospective study by SFGM-TC.

M. Robin, P. Chevallier, G. Guillerm, 2023, Transplantation and cellular therapy.

J. Bourhis, P. Chevallier, I. Yakoub-Agha, 2018, American journal of hematology.

Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS

M. Robin, D. Blaise, G. Guillerm, 2023, Bone Marrow Transplantation.

Ruxolitinib Before Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Patients With myelofibrosis : a Preliminary Descriptive Report Of The JAK ALLO Study, a Phase II Trial Sponsored By Goelams-FIM In Collaboration With The Sfgmtc

R. Porcher, M. Robin, I. Yakoub-Agha, 2013 .

Splenectomy before allogeneic hematopoietic cell transplantation for myelofibrosis: A French nationwide study

M. Robin, P. Chevallier, I. Yakoub-Agha, 2020, American journal of hematology.

[Dose adaptation of the drugs used for hematopoietic stem-cell transplantation in patients with comorbidity: Obesity, chronic renal disease or hepatopathy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

I. Yakoub-Agha, N. Simon, V. Coiteux, 2017, Bulletin du Cancer.

Immunomodulation with Azacytidine and Donor Lymphocyte Infusion Following Sequential Conditioning Allogenic Stem Cell Transplantation Improves Outcome of Unfavorable AML

P. Morel, L. Garçon, J. Marolleau, 2019, Blood.

Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study

R. Houot, S. Chevret, L. Michel, 2023, The Lancet.

Pooled Allogenic Fecal Microbiotherapy MaaT013 for the Treatment of Steroid-Refractory Gastrointestinal Acute Graft-Versus-Host Disease: Results from the Phase IIa Heracles Study and Expanded Access Program

H. Lanic, P. Chevallier, M. Mohty, 2021, Blood.

[Palliative care in hematopoietic stem-cell transplanted patients: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

I. Yakoub-Agha, V. Coiteux, J. Bonneau, 2021, Bulletin du cancer.

The lenalidomide/bortezomib/dexamethasone regimen for the treatment of blastic plasmacytoid dendritic cell neoplasm

J. Marolleau, A. Charbonnier, M. Joris, 2019, Hematological oncology.

L‐asparaginase with methotrexate and dexamethasone is an effective treatment combination in blastic plasmacytoid dendritic cell neoplasm

I. Vaida, G. Damaj, B. Royer, 2013, British journal of haematology.

Ruxolitinib-induced reactivation of cytomegalovirus and Epstein-Barr virus in graft-versus-host disease.

C. François, S. Castelain, J. Marolleau, 2022, Leukemia research.

Evaluation of serum Mucorales PCR for the diagnosis of Mucormycoses: The MODIMUCOR prospective trial.

L. Millon, F. Morio, F. Dalle, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Ruxolitinib For Patients With Primary Or Secondary Myelofibrosis before Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT): A Retrospective Study Of The Société Française De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)

M. Robin, M. Mohty, G. Socié, 2013 .

On Behalf of the SFGM-TC: Prophylactic Donor Lymphocyte Infusion in Patients Treated with Allogeneic Stem-Cell Transplantation for High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia

M. Robin, P. Chevallier, I. Yakoub-Agha, 2023, Acta Haematologica.

Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study

R. Houot, S. Chevret, L. Michel, 2023, The Lancet.

Comparison of Mobilized Peripheral Blood Stem Cells Versus Unmanipulated Bone Marrow Haploidentical Transplantation Using Post-Transplant Cyclophosphamide: A Retrospective Study of SFGM-TC in 176 Patients

I. Yakoub-Agha, L. Mannone, E. Deconinck, 2017 .

Alterations in bone mineral density and bone turnover markers in newly diagnosed adults with lymphoma receiving chemotherapy: a 1-year prospective pilot study.

H. Sevestre, G. Damaj, J. Marolleau, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Safety and Efficacy of Idelalisib Treatment of Chronic Lymphocytic Leukemia (CLL) or Lymphoma Relapsing after Allogeneic Hematopoietic Cell Transplantation (alloHCT): A Survey By the EBMT Chronic Malignancies and Lymphoma Working Parties

J. Gribben, S. Montoto, N. Kröger, 2017 .

Beneficial outcomes and epidemiologics of atypical electrophoretic profiles arising after allogeneic hematopoietic stem cell transplantation for myeloid malignancies.

S. Castelain, A. Galmiche, J. Marolleau, 2021, Current research in translational medicine.

Pooled allogeneic faecal microbiota MaaT013 for steroid-resistant gastrointestinal acute graft-versus-host disease: a single-arm, multicentre phase 2 trial

P. Chevallier, M. Mohty, T. Cluzeau, 2023, EClinicalMedicine.